Literature DB >> 25027361

Cat and dog exposure and respiratory morbidities in cystic fibrosis.

Christopher B Morrow1, Karen S Raraigh2, Deanna M Green1, Scott M Blackman3, Garry R Cutting2, Joseph M Collaco4.   

Abstract

OBJECTIVE: To understand the triggers that may impact respiratory health in cystic fibrosis (CF), including the effects of pets, because environmental factors contribute to one-half of the variation in lung function in patients with CF. STUDY
DESIGN: A total of 703 subjects with CF were recruited through the US CF Twin-Sibling Study. Questionnaires were used to determine the presence/absence of cats and dogs in households with a child with CF. Questionnaires, chart review, and US CF Foundation Patient Registry data were used to track respiratory and infection outcomes.
RESULTS: Within the sample, 47% of subjects reported owning a dog, and 28% reported owning a cat. After adjustment for demographic factors, dog ownership was not associated with any adverse clinical outcomes, and cat ownership was associated an increased risk in developing nasal polyps (aOR 1.66; P = .024) compared with noncat owners. Subjects who owned both cats and dogs were twice as likely to report wheezing compared with other subjects (aOR: 2.01; P = .009). There were no differences in prevalence and age of acquisition for the common CF respiratory pathogens Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus between cat/dog owners and noncat/dog owners.
CONCLUSIONS: Cat ownership was associated with a greater frequency of developing nasal polyps and combined cat-dog ownership was associated with a greater rate of wheezing. Prospective studies are needed to confirm these associations and the potential psychosocial benefits of cat and/or dog ownership.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25027361      PMCID: PMC4177281          DOI: 10.1016/j.jpeds.2014.05.046

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  26 in total

1.  Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion.

Authors:  P W Campbell; R A Parker; B T Roberts; M R Krishnamani; J A Phillips
Journal:  J Pediatr       Date:  1992-02       Impact factor: 4.406

2.  Early childhood wheezing is associated with lower lung function in cystic fibrosis.

Authors:  Clement L Ren; Michael W Konstan; Margaret Rosenfeld; David J Pasta; Stefanie J Millar; Wayne J Morgan
Journal:  Pediatr Pulmonol       Date:  2013-10-01

3.  Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis.

Authors:  J R Curtis; W Burke; A W Kassner; M L Aitken
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

4.  The therapeutic value of pets.

Authors:  F T Fitzgerald
Journal:  West J Med       Date:  1986-01

5.  Exposure of children with cystic fibrosis to environmental tobacco smoke.

Authors:  B K Rubin
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

6.  The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

Authors:  M S Schechter; B J Shelton; P A Margolis; S C Fitzsimmons
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

7.  Transmission of a Panton-Valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog.

Authors:  E van Duijkeren; M J H M Wolfhagen; M E O C Heck; W J B Wannet
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Disease-specific reference equations for lung function in patients with cystic fibrosis.

Authors:  Michal Kulich; Margaret Rosenfeld; Jonathan Campbell; Richard Kronmal; Ron L Gibson; Christopher H Goss; Bonnie Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

9.  Bordetella bronchiseptica infection in pediatric lung transplant recipients.

Authors:  Zarah Ner; Lawrence A Ross; Monica V Horn; Thomas G Keens; Eithne F MacLaughlin; Vaughn A Starnes; Marlyn S Woo
Journal:  Pediatr Transplant       Date:  2003-10

10.  Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis.

Authors:  Christopher H Goss; Stacey A Newsom; Jonathan S Schildcrout; Lianne Sheppard; Joel D Kaufman
Journal:  Am J Respir Crit Care Med       Date:  2004-01-12       Impact factor: 21.405

View more
  3 in total

1.  Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.

Authors:  Claudia Grehn; Patience Eschenhagen; Svenja Temming; Uta Düesberg; Konrad Neumann; Carsten Schwarz
Journal:  Front Cell Infect Microbiol       Date:  2021-01-11       Impact factor: 5.293

2.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Pseudomonas aeruginosa in dogs and cats.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Francesca Baldinelli; Alessandro Broglia; Lisa Kohnle; Julio Alvarez
Journal:  EFSA J       Date:  2022-05-03

Review 3.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.